Tysuna^®

Sunitinib

Product Information

Proprietary Name: Tysuna®
Generic Name: Sunitinib
Dosage Form: Hard Gelatin Capsule
Strengths: 12.5 mg, 25 mg, 50 mg
Indications: Gastrointestinal Stromal Tumor, Renal Cell Carcinoma, Pancreatic Neuroendocrine Tumors

Oncology

Sunitinib is indicated for the treatment of gastrointestinal stromal tumor, renal cell carcinoma, and pancreatic neuroendocrine tumors.